Recent reports suggest that despite an increase in mpox infections among fully vaccinated individuals in 2024, a lasting vaccine-derived immune response exists. The National Advisory Committee on Immunization (NACI) and JAMA Medical News highlight the safety and efficacy of administering mpox and COVID-19 vaccines simultaneously. Data from the Netherlands indicate a decline in mpox cases due to infection- and vaccine-induced immunity, with a preventive vaccination effectiveness of 68.2%.
Infection- plus vaccine-induced immunity led to decline of mpox in Netherlands, data reveal The effectiveness of preventive vaccination was estimated at 68.2%. https://t.co/UZ7xZ9Q0YT https://t.co/kwkIovROfc
JAMA Medical News in Brief: Lower Dose of Mpox Vaccine Was Safe, Effective https://t.co/KB1jUqkLuu
NACI says mpox and COVID-19 vaccines can be safely given at the same time https://t.co/0A06gHC826
mpox and COVID-19 vaccines can be safely given at the same time, says advisory body https://t.co/Y81Sc1JwQs
“Despite a perceived increase in [mpox] infections among fully vaccinated persons during 2024, this report indicates that, to date, persistent vaccine-derived immunologic response among persons who received the 2-dose vaccine series exists," https://t.co/zWUaCxyBtD